# A Study to Characterize Epidemiology, Clinical and Genetic Features of Kallmann Syndrome in Finland

> **NCT00623116** · NA · UNKNOWN · sponsor: **Hospital for Children and Adolescents, Finland** · enrollment: 50 (estimated)

## Conditions studied

- Kallmann Syndrome

## Interventions

- **DRUG:** Short withdrawal of testosterone, gonadotropins or estrogenic compounds (see below)

## Key facts

- **NCT ID:** NCT00623116
- **Lead sponsor:** Hospital for Children and Adolescents, Finland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-12
- **Primary completion:** 2012-12
- **Final completion:** 2025-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2008-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00623116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00623116, "A Study to Characterize Epidemiology, Clinical and Genetic Features of Kallmann Syndrome in Finland". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00623116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*